If you look around, you will likely see many different fitness trackers and smartwatches. The problem with some of these wearables is that they don’t really help when it comes to disease monitoring.
Related: Fitbit CEO to discuss Remote Health monitoring opportunities at the STAT summit
What is Aparito?
However, all hope is not lost, as Aparito is hoping to help change this. The company provides different wearable devices and mobile apps.
These products help deliver various pieces of data to your doctor’s office or hospital. More importantly, the devices help to monitor your health after you have left the doctor.
Between its wearable tech and the mobile apps, Aparito collects data to provide a “multi-dimensional approach”. Using the data will “provide a rich data set allowing clinicians to understand the patient context at all times.”
Wearable Tech & Apps
As we mentioned above, Aparito provides a specific wearable that tracks all kinds of information. The information collected includes the following:
- Movement Type
- Skin Temperature
- Ambient Temperature
- Barometric Pressure
- Heart Rate
- Sleep Patterns
Aparito claims that the tracker is “at the centre of the technology”. This should come as no surprise as all of the information collected syncs with the dedicated apps.
Speaking of those apps, these provide various aspects for individuals to keep track of. This includes Medication Adherence, Visit Monitoring, Event Capture, and Patient Reported Outcomes.
Combining the tracker with Aparito’s applications will collect and provide all of the information you need. This will help provide even more insight for the various studies that you are apart of.
There is even a dashboard that is used to provide “up to date patient and study wide indicators”. These will help provide a way for clinicians to determine the questions that need to be answered.
Additionally, Aparito is using Machine Learning tools to “conduct progression analysis”. All of this combined will help to provide patterns, correlations, and more for the statisticians.
In a quote provided by Forbes, CEO Elin Haf Davies states that “less than 3% of a patient’s experience is captured at a clinical trial because it mostly happens outside of hospitals walls.”
The company is looking to change that percentage, and provide a fuller story during trials.
If you think that Aparito is going to be a “flash in the pan”, you may want to think again. The company has partnered with IBM, Microsoft, and Amazon for its infrastructure.
The company also has been listed as one of the biggest up-and-comers in the space. All of this will help improve clinical trials and will hopefully make lives easier for the patients participating.
Let us know what you think about what Aparito is doing, and if you see this is as a good thing or bad.